Ballotta, D., Pfeiffer-Gerschel, T., Goosdeel, A.
Is UNGASS 2016 the turning point in international drug policy? [Editorial]Been, F., Bijlsma, L., Benaglia, L., Berset, J.-D., Botero-Coy, A.M., Castiglioni, S., Kraus, L., Zobel, F., Schaub, M., Bücheli, A., Hernandez, F., Delemont, O., Esseiva, P., Ort, C.
Assessing geographical differences in illicit drug consumption - A comparison of results from epidemiological and wastewater data in Germany and SwitzerlandMaron, J., Kraus, L., Pogarell, O., Gomes de Matos, E., Piontek, D.
Occupational inequalities in psychoactive substance use: a question of conceptualization?Amundsen, E.J., Bretteville-Jensen, A.L., Kraus, L.
Estimating incidence of problem drug use using the Horwitz-Thompson estimator – A new approach applied to people who inject drugs in Oslo 1985–2008Pfeiffer-Gerschel, T.
Fit for purpose. Perspektiven der modernen DrogenbehandlungHöhne, B., Pabst, A., Hannemann, T., Kraus, L.
Patterns of concurrent alcohol, tobacco, and cannabis use in Germany: prevalence and correlatesLegleye, S., Piontek, D., Pampel, F., Goffette, C., Khlat, M., Kraus, L.
Is there a cannabis epidemic model? Evidence from France, Germany and USABühler, A., Bühringer, G.
Prävention von substanzbezogenen StörungenMustermann, Max, Testen, Till
Prävention von substanzbezogenen Störungen
IFT Institut für Therapieforschung
Leopoldstraße 175
80804 München
Tel. +49 89 360804-0
Fax +49 89 360804-19
Email: ift@ift.de
